Eventide Asset Management LLC Increases Stock Holdings in STERIS plc $STE

Eventide Asset Management LLC grew its holdings in shares of STERIS plc (NYSE:STE) by 1.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 168,608 shares of the medical equipment provider’s stock after purchasing an additional 3,009 shares during the period. Eventide Asset Management LLC owned about 0.17% of STERIS worth $40,493,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Spurstone Advisory Services LLC purchased a new stake in STERIS during the 2nd quarter worth approximately $29,000. Geneos Wealth Management Inc. boosted its position in STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 104 shares during the period. Loomis Sayles & Co. L P acquired a new position in shares of STERIS in the second quarter worth $54,000. Generali Investments Management Co LLC acquired a new position in shares of STERIS in the second quarter worth $56,000. Finally, Atticus Wealth Management LLC purchased a new stake in shares of STERIS during the second quarter worth $68,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on STE shares. Wall Street Zen upgraded STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research note on Tuesday, October 14th. Seven analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, STERIS presently has an average rating of “Moderate Buy” and an average price target of $273.50.

STERIS Stock Down 0.3%

STERIS stock opened at $251.72 on Friday. The stock has a market cap of $24.71 billion, a PE ratio of 36.17 and a beta of 1.01. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.37 and a quick ratio of 1.63. The stock’s fifty day moving average is $251.25 and its two-hundred day moving average is $243.85. STERIS plc has a 1-year low of $200.98 and a 1-year high of $268.60.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the prior year, the business posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, sell-side analysts expect that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Tuesday, November 18th will be given a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Tuesday, November 18th. STERIS’s payout ratio is currently 36.21%.

Insider Activity at STERIS

In other news, VP Julia Madsen sold 5,008 shares of the company’s stock in a transaction on Friday, November 21st. The shares were sold at an average price of $262.00, for a total value of $1,312,096.00. Following the completion of the transaction, the vice president owned 10,710 shares in the company, valued at approximately $2,806,020. This represents a 31.86% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, VP John Adam Zangerle sold 15,000 shares of STERIS stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the sale, the vice president owned 33,669 shares in the company, valued at $8,926,998.66. This represents a 30.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 25,203 shares of company stock worth $6,624,667. Corporate insiders own 1.07% of the company’s stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.